Pietras et al. reported that OPN-CD44 interactions not only enhance cancer stem cell phenotypes but also promote aggressive tumor growth in vivo in GSCs existing in the perivascular niche of proneural GBM [15]. The gene discussed is CD44; the disease is glioblastoma.